KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Accounts Payables (2019 - 2025)

Hims & Hers Health's Accounts Payables history spans 7 years, with the latest figure at $143.3 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 57.14% year-over-year to $143.3 million; the TTM value through Dec 2025 reached $143.3 million, up 57.14%, while the annual FY2025 figure was $143.3 million, 57.14% up from the prior year.
  • Accounts Payables for Q4 2025 was $143.3 million at Hims & Hers Health, down from $198.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $198.4 million in Q3 2025 and bottomed at $13.2 million in Q1 2021.
  • The 5-year median for Accounts Payables is $40.1 million (2023), against an average of $58.3 million.
  • The largest annual shift saw Accounts Payables skyrocketed 71769.23% in 2021 before it increased 16.78% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $19.6 million in 2021, then skyrocketed by 64.78% to $32.4 million in 2022, then soared by 33.08% to $43.1 million in 2023, then soared by 111.7% to $91.2 million in 2024, then soared by 57.14% to $143.3 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Accounts Payables are $143.3 million (Q4 2025), $198.4 million (Q3 2025), and $105.0 million (Q2 2025).